Verge Genomics

Verge Genomics is a biopharmaceutical company in the field of drug discovery. They’ve created a cutting-edge, all-in-human AI-driven platform to accelerate the discovery of new medications. The platform leverages patient genetic information, gene expression data, and epigenomics to discover novel therapeutic gene targets, forecast the efficacy of medications, and categorize patient subgroups to enhance clinical trial success. They are uncovering drugs that significantly enhance patient results and fundamentally reduce the expenses associated with pharmaceutical development.